S
INCE the introduction of cerebrospinal fluid (CSF) shunts for the control of hydrocephalus, infection has assumed a major role in both the morbidity and mortality of this disorder. Despite the use of routine prophylactic antibiotics and strict adherence to the principles of antisepsis, the incidence of infection after primary placement has ranged from 6% to 39%, 6-s' 25-~7 and it increases with subsequent revisions. 2e Therapeutic efforts have been directed at sterilization of the colonized shunt and blood stream by two basic methods. A surgical approach, entailing either complete or incomplete removal of the shunt combined with concomitant systemic antibiotic therapy, has been adopted by many? , 18, 19, 25 Proponents of a nonsurgical approach have fallen into two groups. Schimke, et al., 24 have claimed that high-dose systemic antibiotics alone will eradicate the offending micro-organism in both the central nervous system and blood stream. Others have advocated intraventricular or intrashunt antibiotic instillation, combined with high doses of antibiotics by the systemic route. 11, 14, 28 At the Children's Hospital Medical Center of the University of Cincinnati, emphasis has been placed on intraventricular antibiotic administration in an effort to avoid surgical procedures. Dosages and frequency of administration have been largely empirical. We are reporting the observations that have been made during the past 2 years to permit greater accuracy and predictability in achieving effective antibiotic levels within the CSF compartment. The report is not intended to recommend a treatment program for shunt infection, but rather to establish the effectiveness of intraventricular antibiotic instillation in maintaining adequate therapeutic concentrations.
Clinical Material and Methods
From July, 1976, to June, 1978, 20 patients received intraventricular antibiotics. Sixteen of the 20 patients had CSF shunts in place, 11 ventriculoperitoneal and five ventriculojugular, while four patients with ventriculitis were treated by direct ventricular instillation. In the 16 patients with shunts, 12 shunts were considered to be functioning satisfactorily at the time of infection, as documented by ventricular fluid pressure and the absence of clinical symptoms or signs.
The criteria established for a diagnosis of shunt infection consisted of the clinical presence of fever with or without leukocytosis, positive ventricular fluid culture from aspiration of the shunt reservoir 15a5 on two separate occasions, and, in all cases of vascular shunt systems, positive blood cultures of the same organism found in the CSF. Patients with peritoneal shunts, as previously reported, uniformly had negative blood cultures. 25 The choice of antibiotic was based on the specific disc susceptibility of the cultured organism. 2 As in previous studies, Staphylococcus epidermidis dominated, with 10 patients (50%) harboring this organism. 7a5,28 Three shunts were infected with Staphylococcus aureus (15%), two by Hemophilus influenzae (10%), and one each by Klebsiella and Enterococcus (5%). Of the four patients treated without shunt systems, three patients had Escherichia Eight patients received 10 courses of gentamicin intraventricularly. These courses ranged in duration from 4 to 16 days. Daily injections were performed in eight of the 10 courses, while alternate-day injections were administered in the remaining two courses.
Seven patients received 11 courses of intraventricular cephalothin in courses ranging in length from 4 to 19 days. Two of the patients had been treated with other antibiotics unsuccessfully.
It may be noted that because of resistance to antibiotic treatment, several patients received courses of treatment with more than one antibiotic. Two of the patients (Cases 1 and 11) received courses of all three antibiotics because of extreme difficulty in sterilizing their shunt systems.
Specific intraventricular antibiotic doses or ranges are shown in Table 1 . No alteration in the intraventricular dose was made for age, body weight, surface area, or presumed discrepancies in ventricular volume. Systemic antibiotics were administered in all cases concomitant with intraventricular therapy. The same antibiotic chosen for intraventricular injection was usually employed for parenteral therapy in appropriate doses based on body weight and surface area.
Nearly all injections and CSF samplings were made by one of the authors (S.W.), using the same technique with each injection. This consisted of a meticulous Betadine scrub to the shaved scalp directly overlying the reservoir site. The skin was then entered using a No. 25 needle which was advanced into the reservoir. The actual puncture site was varied from day to day. Then 2 ml of CSF was gently aspirated in separate 1-ml aliquots and placed in sterile test tubes for evaluation of CSF chemistries, or for cell counts or cultures. Next, 2 ml of fluid was aspirated and assayed for the antibiotic level? ~ These assays were performed at 24, 48, or 72 hours after the preceding antibiotic injection, depending upon what dose schedule had been adopted. Following this procedure, the specific antibiotic was then injected. Gentle barbotage was performed as the total volume of antibiotic was generally quite small, and thorough mixing with the ventricular fluid was desired. This technique for antibiotic assay was believed to insure that the actual fluid assayed was representative of intraventricular fluid. ~ Minimum inhibitory (MIC) and minimum bactericidal concentrations (MBC) were established, based on quantitative antibiotic susceptibility using a broth dilution technique, a~ These values were then compared to the actual ventricular fluid antibiotic concentration to evaluate the effect of therapy and to judge the need for alterations in dosage. In two patients who received combination alternate-day therapy (Cases 6 and 11), inhibitory and bactericidal titers of the patient's CSF against the patient's infecting pathogen were established on a daily basis as an additional means for evaluating treatment?
Results

Methicillin
The average concentration of methicillin 24 hours after injection was greater than 13.5 #g/ml in all patients ( Table 2 ). Case 5, the only patient with a Pudenz flushing device, maintained ventricular fluid concentrations of methicillin greater than 15.7 #g/ml, only after manual occlusion of the shunt tubing over the mastoid was initiated during the injection phase of the preceding day.
Determinations of average CSF concentration 48 and 72 hours after injection are also shown in Table 2 . In six of eight observations, the antibiotic levels obtained 48 hours after cessation of therapy represented a significant concentration, being greater than 16 ug/ml. Determinations at 72 hours were few, but again revealed that a considerable concentration may be present even at this delayed interval. One patient whose shunt was not functioning demonstrated significant intraventricular antibiotic concentration 144 hours after the last injection.
Alternate-day therapy with methicillin, 100 mg, resulted in 48-hour antibiotic levels greater than 16 ~g/ml in two patients, and 2.0 #g/ml in one patient. Of the four patients who received methicillin, 200 mg, every other day, three demonstrated levels greater than 16 #g/ml at 48 hours.
Six patients had methicillin assays performed 24 hours after the initial dose had been instilled. Levels greater than 16 ug/ml were observed in every patient. The antibiotic levels obtained at 24 hours after the standard dosage represented at least a four-to 40-fold increase over the established MIC.
Of the seven patients receiving at least 7 days of intraventricular methicillin, five (71%) were cured of the shunt infection with one course of therapy. Two patients required either further therapy with a different intraventricular antibiotic or a complete shunt removal before a cure was obtained.
Prophylactic therapy was instituted in two patients with CSF-cutaneous fistulas. Infection of the shunt apparatus did not develop. One patient was cured of an S. epidermidis ventriculitis by daily instillation of methicillin through an external ventricular drain. Table 3 shows that ventricular fluid concentrations of gentamicin ranged from 5.3 #g/ml to more than 12 #g/ml at 24 hours. These values represent levels from 1.6 to42 times the MIC of the organism. The 48-hour trough concentrations ranged from 4.4 to 27 times the MIC.
Gentamicin
It is noteworthy that 24-hour concentrations were adequate in both the patients (Cases 6 and 11) who were treated on an alternate-day schedule. However, average 48-hour concentrations fell below the rather elevated MIC in one of these patients.
Five patients with shunt infections were treated with gentamicin. Four (80%) were cured with the initial course of treatment, and one (Case 1) suffered a relapse. The three patients who were treated for E. coli ventriculitis, using a ventriculostomy reservoir or by ventricular puncture, were all cured with the initial intraventricular antibiotic course.
Cephalothin
Six treatment courses using cephalothin, 100 mg daily, are shown in Table 4 . Ventricular fluid concentrations at 24 hours were from 27 to 287 times the MIC. The wide variation in actual values was based on the inability to determine exact ventricular fluid concentrations early in the study. Recent capabilities in dilution techniques now allow for an exact determination of all antibiotics routinely used.
Levels of antibiotic at 48 hours were well above the MIC in seven of the nine trials. In the two patients with undetectable antibiotic at 48 hours, the injection dosage was 50 mg, while all patients receiving 100-rag injections maintained levels many times the MIC.
Four patients were treated with a daily 50-mg injection. Levels of antibiotic were from 53.5 to 211 times the MIC. In one patient the intraventricular dosage was lowered to 25 mg, but the levels remained over 100 times the MIC.
Six patients of a total of seven (86%) were cured of the shunt infection with a single 2-week treatment course. One patient failed and another was switched to a different antibiotic after only three injections, based on the specific disc susceptibilities and MIC.
General Comments
Cultures of the ventricular fluid were examined periodically during the course of therapy. Analysis of patients who developed recurrent infection revealed that the organism responsible was always the same as in the initial infection. Positive cultures in this group of patients were obtained only when concomitant ventricular fluid concentration of antibiotic was either far below the MIC or undetectable. Determination of the MIC of the antibiotic employed in the initial treatment course often revealed a two-to threefold increase in the necessary concentration required to inhibit the growth of the recurrent bacteria. Although acquired antibiotic resistance was suggested in some patients, it was not consistent in all.
Ventricular fluid was periodically sampled for protein and glucose concentrations and cell counts. Protein values tended to rise during the treatment course, although this was not consistent among all patients. Glucose values tended to remain at pretreatment levels, although fluctuations were noted. Only two patients demonstrated markedly depressed CSF glucose levels at the start of treatment. In both of these patients, the glucose level rose during the course of therapy. Neither of these patients had a shunting device at the time of treatment. No characteristic trend in protein or glucose values could be established in relation to the specific antibiotic employed.
If an elevation in cellular elements was found within the ventricular system at the start of treatment, a tendency toward reduction in absolute cell numbers and a shift to predominantly mononuclear cells was noted as therapy progressed. In general, however, CSF pleocytosis was not a common finding.
Two patients manifested the characteristic renal and immunological changes of shunt glomerulonephritis? a~ Two weeks of intraventricular and systemic antibiotic therapy resulted in return of laboratory parameters to normal values. There has been no evidence of recurrence, and neither patient has demonstrated permanent renal impairment.
Before institution of intraventricular therapy, several patients had received high-dose parenteral antibiotics. Ventricular fluid assays performed at the time of the first intraventricular antibiotic injection demonstrated levels far below the MIC in all cases, despite the antibiotic employed. This is in agreement with other studies on antibiotic penetration into the intact blood-CSF barrier? ~
Discussion
Intraventricular antibiotic therapy in the treatment of shunt infections offers several advantages over other previously recommended treatment modes. Systemic antibiotics alone, because of poor penetration into the CSF, have almost always met with failure. In several of our patients, ventricular fluid antibiotic concentrations before the start of treatment were far below the MIC, despite several days of high-dose systemic therapy. Partial or complete shunt removal, as advocated by many, is not without morbidity and mortality. Complete removal, if possible, carries the risk of intracranial hypertension and usually necessitates another operative procedure for replacement. Immediate replacement of an entirely new shunt system can be technically difficult if the shunt has been functioning well and the ventricles are small. Replacement of the peritoneal catheter may be hindered by adhesions, while removal of a ventriculoatrial shunt requires sacrifice of the vein. The use of frequent ventricular taps to relieve intracranial pressure in the shunt-dependent child may cause structural brain damage, 2z and the incidence of secondary infection and malfunction with constant external ventricular drainage is high."
We have demonstrated in this study that antibiotic concentrations in the ventricular fluid can be maintained at very high levels when compared to the established MIC in all patients following the therapeutic protocol. These findings are consistent with results of the relatively few studies that have been published previously. Simpson, et al., z8 treated 14 cases of ventriculitis with intraventricular cephalothin in varying doses. They found very high concentrations at 24 hours, although the exact level was highly dependent upon the presence of a functioning shunt system. Twelve patients were considered cured (86%). Salmon 2a reviewed the treatment of 10 patients with ventriculitis complicating meningitis, and concluded that intraventricular therapy was indicated for complicated cases of neonatal meningitis. Blevins and his colleagues' recently reported wide variability from patient to patient in the concentration of gentamicin after ventricular instillation. Newman and Holt ~7 treated three patients with short courses of intraventricular gentamicin. A standard dose of 1 mg per day was given, resulting in CSF antibiotic levels of between 1 to 6/ag/ml. They concluded that parenteral therapy alone could not achieve these levels within the CSF, and used this method to cure all three patients with Pseudomonas and Klebsiella ventriculitis. Moellering and Fischer la were able to cure a patient with Proteus meningitis and ventriculitis only after five daily intraventricular injections of 2 mg of gentamicin. Instillation of 1 mg of gentamicin into the lumbar intrathecal space had previously failed to elevate the ventricular fluid concentration of antibiotic to appropriate levels. Ventricular fluid levels of 2.4 to 10/ag/ml, 21 to 30 hours after instillation, resulted in sterile cultures and a clinical cure. Wilson, et al., 3~ found wide variation in CSF antibiotic concentration in seven patients with infected ventricular shunts.
Toxicity was rarely observed in this study? 2 One of our patients with a known seizure disorder, which was under good control, developed a single generalized seizure 3 days after treatment with cephalothin had been concluded. No further episodes developed, and excellent control with medication continues to exist. Another patient without a prior seizure history developed generalized seizure activity for 2 days while being treated with cephalothin. Ventricular fluid concentrations were allowed to fall and daily dose adjustment resulted in no further episodes. An electroencephalogram was normal several days after the seizures had ceased. No seizures were ever noted with intraventricular gentamicin or methicillin. Depression of bone marrow and anaphylactic responses were not seen. While structural autopsy findings resembling disseminated necrotizing leukoencephalopathy has been reported in a patient receiving intrathecal gentamicin, no clinical correlation or neurological deficit could be attributed to the lesion? 1
McLaurin '2 has shown that nearly two-thirds of all shunt infections can be cured without surgical intervention. In the present series, 13 of the 14 patients (93%) with CSF shunts who were treated with a full course of therapy were cured of the infection by the use of intraventricular therapy alone. One patient (Case 1) required a complete shunt removal.
Conclusions
Antibiotic levels within the ventricular system were well above the MIC 24 hours after intraventricular injection in all patients treated in this study using the doses we have presented. Ventricular fluid levels at 48 hours were usually very high, but inadequate concentrations were also found. Periodic monitoring of both the ventricular fluid antibiotic level and the MIC is essential during the course of therapy so that intraventricular dose adjustments can be made if levels are not satisfactory. Our goal at this time is to establish antibiotic levels at least five times the MIC, although even higher levels are preferred. The safety of this treatment mode has been established in over 50 patients treated at this institution.
Final cultures should not be obtained within the first 72 hours of completion of a course of intraven-tricular therapy as, in some cases, significant antibiotic will still be present. It is only after the antibiotic is undetectable in the ventricular fluid that cultures can be considered reliable in evaluating therapy. We prefer to have two or three sterile cultures at this time before considering the patient cured.
The treatment of infected CSF shunts remains a difficult therapeutic challenge to the neurosurgeon. Further knowledge about antibiotic concentrations during the course of intraventricular therapy should aid in evaluating the effectiveness of nonsurgical treatment. With continued improvement in the therapy of shunt infections, enhancement in the overall prognosis and well being of the shunted patient is expected.
